United Therapeutics (NASDAQ:UTHR) Now Covered by Analysts at Cantor Fitzgerald
Cantor Fitzgerald initiated coverage on shares of United Therapeutics (NASDAQ:UTHR – Free Report) in a research report released on Monday, Marketbeat reports. The brokerage issued an overweight rating and a $405.00 price objective on the biotechnology company’s stock. Several other equities research analysts have also recently weighed in on the stock. Wall Street Zen cut […]
Cantor Fitzgerald initiated coverage on shares of United Therapeutics (NASDAQ:UTHR – Free Report) in a research report released on Monday, Marketbeat reports. The brokerage issued an overweight rating and a $405.00 price objective on the biotechnology company’s stock. Several other equities research analysts have also recently weighed in on the stock. Wall Street Zen cut […]
